Previous close | 86.37 |
Open | 86.44 |
Bid | 85.92 x 800 |
Ask | 86.99 x 900 |
Day's range | 85.83 - 86.72 |
52-week range | 57.55 - 86.72 |
Volume | |
Avg. volume | 689,357 |
Market cap | 8.712B |
Beta (5Y monthly) | 0.82 |
PE ratio (TTM) | 22.65 |
EPS (TTM) | 3.82 |
Earnings date | 30 July 2024 - 05 Aug 2024 |
Forward dividend & yield | 0.60 (0.69%) |
Ex-dividend date | 01 July 2024 |
1y target est | 95.30 |
STERIS' (STE) fourth-quarter performance in AST is dented by a decline in capital equipment revenues. The contraction of margins is concerning.
Charles River's (CRL) Manufacturing and RMS business segments report organic revenue growth.
Robust revenues from the Screening and Precision Oncology segments contributed to the Exact Sciences' (EXAS) first-quarter top line.